UK markets open in 4 hours 51 minutes

Definitive Healthcare Corp. (DH)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.02+0.30 (+5.24%)
At close: 04:00PM EDT
6.02 0.00 (0.00%)
After hours: 04:04PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.72
Bid5.98 x 100
Ask6.09 x 100
Day's range5.72 - 6.16
52-week range4.38 - 12.37
Avg. volume844,460
Market cap709.969M
Beta (5Y monthly)1.31
PE ratio (TTM)N/A
EPS (TTM)-1.76
Earnings date05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.61
  • GlobeNewswire

    Definitive Healthcare Announces Timing of Its Second Quarter 2024 Financial Results Conference Call and Webcast

    FRAMINGHAM, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its second quarter ended June 30, 2024, on Monday, August 5, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the event will be availabl

  • GlobeNewswire

    Definitive Healthcare launches redesigned mobile app to enhance access to healthcare commercial intelligence

    DH View Suite gives sales and marketing teams instant access to critical intelligence right from their mobile devicesFRAMINGHAM, Mass., July 09, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of a redesigned mobile app for its popular View Suite platform. The new DH View Suite mobile app provides sales and marketing professionals with on-demand access to vital data and intelligence, maximizing their efficien

  • GlobeNewswire

    Definitive Healthcare Corp. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    FRAMINGHAM, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that Definitive Healthcare’s Board of Directors (the “Board”) granted inducement awards consisting of 1,137,038 performance-based restricted stock units (“PSUs”) and 1,170,047 time-based restricted stock units (“RSUs”) to Kevin Coop, Definitive Healthcare’s new Chief Executive Officer and member of the Board, effective June 24, 2024. T